FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

787749007: Product containing only risankizumab in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3776764015 Risankizumab only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3776765019 Product containing only risankizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3776764015 Risankizumab only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3776765019 Product containing only risankizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risankizumab only product in parenteral dose form Is a Risankizumab-containing product in parenteral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab only product in parenteral dose form Is a Product containing only risankizumab (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab only product in parenteral dose form Count of base of active ingredient un false Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab only product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Risankizumab true Inferred relationship Existential restriction modifier (core metadata concept) 1

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely risankizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Is a True Risankizumab only product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab 90.361 mg/mL solution for injection Is a True Risankizumab only product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start